Theratechnologies BAIIA
Quel est le BAIIA de Theratechnologies?
Le BAIIA de Theratechnologies, Inc. est -$22.62
Quelle est la définition de BAIIA?
Le BAIIA est le bénéfice avant intérêts, impôts, dépréciations et amortissements d’une entreprise. Il s’agit d’une mesure comptable calculée à partir du bénéfice net avant de sustraire les intérêts, impôts et amortissements d’une entreprise, comme mesure de la rentabilité opérationnelle courante de l’entreprise.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
BAIIA des entreprises dans Health Care secteur sur TSX par rapport à Theratechnologies
Que fait Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Entreprises avec baiia similaire à Theratechnologies
- Jaykay Enterprises a BAIIA de -₨22.74
- Virnetx Corp a BAIIA de -$22.74
- Hong Kong Finance Investment a BAIIA de -HKD$22.73
- Dafeng Port Heshun Technology a BAIIA de -HKD$22.70
- Green Organic Dutchman a BAIIA de -CAD$22.69
- PyroGenesis Canada a BAIIA de -CAD$22.68
- Theratechnologies a BAIIA de -$22.62
- Winfull a BAIIA de -HKD$22.62
- Honworld a BAIIA de -¥22.61
- Asia-Pac Investment a BAIIA de -HKD$22.60
- National Access Cannabis a BAIIA de -CAD$22.58
- Ching Lee a BAIIA de -HKD$22.54
- Axon Enterprise Inc a BAIIA de -$22.53